Literature DB >> 26167655

Efficacy and Safety of Percutaneous Nephrolithotomy in Children with Previous Renal Stone Operations.

Hussein A Aldaqadossi1, Yousef Kotb2, Khalid Mohi1.   

Abstract

PURPOSE: To determine the impact of open pyelolithotomy or nephrolithotomy on the results and complications of subsequent percutaneous nephrolithotomy (PCNL) in children. PATIENTS AND METHODS: We retrospectively reviewed the files of 121 children with 135 renal units (RUs) who underwent PCNL between February 2008 and October 2014. We compared RUs with no previous intervention (group 1, 87 RUs) with those that had preceding open pyelolithotomy or nephrolithotomy (group 2, 48 RUs). The demographic characteristics, mean operative time, mean fluoroscopy time, mean hemoglobin changes, number of percutaneous accesses, analgesic requirement, mean hospitalization time, stone-free rate, and complications were all reported and compared.
RESULTS: The study included 135 RUs in 121 children (74 boys and 47 girls) who underwent PCNL. No statistical differences were detected between the two groups in terms of age, sex, stone size, stone laterality, and stone opacity. Mean operative time, mean fluoroscopy time, mean hemoglobin change, number of percutaneous accesses, supracostal access, analgesic requirement, and hospitalization stay were similar in each group (P>0.05). The stone-free rate in group 1 was higher than that in group 2 (81.61% vs 79.17%). This was not statistically significant (P>0.05), however.
CONCLUSION: Previous open pyelolithotomy or nephrolithotomy does not affect the efficacy and morbidity of subsequent PCNL in pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26167655     DOI: 10.1089/end.2014.0912

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  1 in total

1.  Impact of previous open renal surgery on the outcomes of subsequent percutaneous nephrolithotomy: a meta-analysis.

Authors:  Henglong Hu; Yuchao Lu; Lei Cui; Jiaqiao Zhang; Zhenyu Zhao; Baolong Qin; Yufeng Wang; Qing Wang; Shaogang Wang
Journal:  BMJ Open       Date:  2016-04-28       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.